Ladenburg Thalmann Financial Services’s Merrimack Pharmaceuticals, Inc. MACK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | $0 | Hold |
60
| – | – | ﹤0.01% | 5717 |
|
|
2019
Q3 | $0 | Sell |
60
-1,933
| -97% | – | ﹤0.01% | 5665 |
|
|
2019
Q2 | $9K | Hold |
1,993
| – | – | ﹤0.01% | 4507 |
|
|
2019
Q1 | $11K | Hold |
1,993
| – | – | ﹤0.01% | 4348 |
|
|
2018
Q4 | $7K | Buy |
1,993
+1,917
| +2,522% | +$6.73K | ﹤0.01% | 4485 |
|
|
2018
Q3 | $0 | Hold |
76
| – | – | ﹤0.01% | 5562 |
|
|
2018
Q2 | $0 | Hold |
76
| – | – | ﹤0.01% | 5229 |
|
|
2018
Q1 | $0 | Buy |
+76
| New | – | ﹤0.01% | 5357 |
|
|
2016
Q3 | – | Sell |
-636
| Closed | -$27K | – | 4975 |
|
|
2016
Q2 | $27K | Sell |
636
-635
| -50% | -$27K | ﹤0.01% | 3149 |
|
|
2016
Q1 | $84K | Sell |
1,271
-1,907
| -60% | -$126K | ﹤0.01% | 2198 |
|
|
2015
Q4 | $198K | Hold |
3,178
| – | – | ﹤0.01% | 1592 |
|
|
2015
Q3 | $213K | Buy |
3,178
+293
| +10% | +$19.6K | ﹤0.01% | 1447 |
|
|
2015
Q2 | $281K | Hold |
2,885
| – | – | 0.01% | 1370 |
|
|
2015
Q1 | $270K | Buy |
2,885
+762
| +36% | +$71.3K | 0.01% | 1372 |
|
|
2014
Q4 | $189K | Buy |
2,123
+191
| +10% | +$17K | ﹤0.01% | 1469 |
|
|
2014
Q3 | $133K | Hold |
1,932
| – | – | ﹤0.01% | 1450 |
|
|
2014
Q2 | $111K | Hold |
1,932
| – | – | ﹤0.01% | 1542 |
|
|
2014
Q1 | $77K | Hold |
1,932
| – | – | ﹤0.01% | 1667 |
|
|
2013
Q4 | $81K | Buy |
+1,932
| New | +$81K | ﹤0.01% | 1599 |
|
|
2013
Q3 | – | Sell |
-318
| Closed | -$17K | – | 3908 |
|
|
2013
Q2 | $17K | Buy |
+318
| New | +$17K | ﹤0.01% | 2447 |
|